Assessing Changes in Pharmacokinetics of Drugs in Liver Disease is an online workshop hosted by the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) and the FDA.
Key Topics of disussion include:
-
Relevant biomarkers and their predictive ability to identify changes in biotransformation and transport capacity of the liver
-
Classification of degree of impairment in biotransformation and transport capacity of the diseased liver to aid drug development and dosing recommendations
-
Research on potential differences in PK in different underlying liver diseases
-
Research on the potential to utilize modelling and simulation approaches to obtain dosing recommendations in patients with impaired hepatic function.
FOR MORE INFORMATION:
More information about this workshop, is available HERE.